Sodium glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: a systematic review and meta-analysis

Eur J Prev Cardiol. 2022 May 6;29(6):e227-e229. doi: 10.1093/eurjpc/zwab189.
No abstract available

Publication types

  • Meta-Analysis
  • Systematic Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Glucose
  • Heart Failure* / diagnosis
  • Heart Failure* / drug therapy
  • Humans
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
  • Stroke Volume
  • Symporters*

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Symporters
  • Sodium
  • Glucose